CHAS is an international subsidiary of CHA Health Systems, known for its women’s health and fertility expertise as one of the largest and most diversified private healthcare services groups in Asia with a focus on reproductive medicine, women’s health, stem cell research and wellness care.
SINGAPORE (Feb 20): Singapore Medical Group (SMG) says its 6.86% shareholder CHA Healthcare Singapore (CHAS) is increasing its stake in the group to 24.13% by purchasing existing shares from certain SMG shareholders via a $50 million investment.
This comes after the group called for a trading halt following a 4.4% surge in its share price to 47 cents within the first three hours of trading today.
